Please login to the form below

Not currently logged in
Email:
Password:

NovoEight

This page shows the latest NovoEight news and features for those working in and with pharma, biotech and healthcare.

New data could unlock bigger market for Roche’s Hemlibra

New data could unlock bigger market for Roche’s Hemlibra

Novo Nordisk is developing a once-weekly version of its established NovoEight product - called N8-GP - that could be filed next year.

Latest news

  • US approval for Novo's Factor XIII drug Tretten US approval for Novo's Factor XIII drug Tretten

    In October, Novo secured US approval for NovoEight, a new long-acting Factor VIII for people with haemophilia A (turoctocog alfa), while it also has NN7999, a long-acting recombinant coagulation

  • Novo Nordisk wins US approval for haemophilia treatment Novo Nordisk wins US approval for haemophilia treatment

    US regulators have approved NovoEight, Novo Nordisk's new treatment for people with haemophilia A. ... The US approval follows a positive recommendation for NovoEight from the European Medicines Agency (EMA) made last month.

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    Novo Nordisk's haemophilia drug. Among the drugs backed by the CHMP, which provides guidance to the European Medicines Agency (EMA), was Novo Nordisk's NovoEight (turoctocog alfa) for use in ... NovoEight has also been filed for approval in the US, Japan,

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics